Related Experiment Video

Updated: Aug 31, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

[Repeated coronary angioplasty due to restenosis and disease progression - a case report]

Tamara Parczewska1, Tomasz Wysoczański, Krzysztof Wrabec

  • 1Oddział Kardiologiczny Wojewódzkiego Szpitala Specjalistycznego, Wrocław, Poland.

Kardiologia Polska
|September 23, 2003
PubMed

Insights

This case study details a patient with coronary artery disease (CAD) who experienced recurrent angina despite multiple percutaneous coronary interventions, including stenting for dissection and restenosis. It highlights the complexities of managing complex CAD cases.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • A 71-year-old male presented with exercise-induced angina and two-vessel coronary artery disease (CAD).
  • Initial treatment involved successful angioplasty with stent implantation in the circumflex artery, providing temporary relief.

Observation:

  • The patient later underwent angioplasty of the left anterior descending (LAD) artery, complicated by dissection requiring dual stent implantation.
  • Recurrent angina developed three months post-procedure, necessitating repeat coronary angiography.

Findings:

  • Coronary angiography revealed in-stent restenosis in the LAD.
  • Repeat angioplasty yielded good angiographic results but did not resolve the patient's angina.

Implications:

  • This case underscores the challenges in managing complex coronary artery disease and in-stent restenosis.
  • It prompts a discussion on current ACC/AHA guidelines for percutaneous coronary interventions in intricate CAD scenarios.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...